Investing, US News

Albert Bourla: Pfizer Could Have A New Vaccine Against Omicron Covid Variant In Less Than 100 Days

NYSE:PFE Asymptomatic vaccine manufacturing Pfizer CEO Albert Bourla

Following is the unofficial transcript of a CNBC interview with Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Monday, November 29th. Following is a link to video on CNBC.com: Q3 2021 hedge fund letters, conferences and more Pfizer Could Have A New Vaccine Against Omicron Covid Variant […]

Jump To The Original Source

Facebook Comments

Check Also

EU Sees Economic Contraction if Russian Gas Supplies Are Halted

Even without a disruption to energy supplies, the ...

Archives